The Therapeutic Goods Administration (TGA) of Australia’s Department of Health has issued a monitoring communication to advise consumers and health professionals that it is “undertaking a comprehensive review of the safety of therapeutic goods containing both caffeine and oxedrine.” These ingredients are apparently used in energy supplements, appetite suppressants and weight- loss products. TGA contends that use of the products as recreational stimulants “could create significant health risks, especially if used in combination with illicit drugs or other stimulants.” Among the purported adverse events that have been reported to TGA are teenagers experiencing “serious cardiovascular toxicity” when using products with these ingredients along with alcohol and caffeinated energy drinks. Other reported effects include fainting, increased heart rate, raised blood pressure, stroke, and heart attack. TGA suggests that parents address these issues with their teenage children and that all consumers read product labels carefully to moderate caffeine intake.